Target intelligence / Profile preview

Apicoplast Ribosome (Plasmodium)

Molecular classification: Ribosome, Protein Synthesis Machinery

Overview

The Plasmodium apicoplast ribosome represents a streamlined but essential prokaryote-like translation system embedded within a eukaryotic pathogen. Its unique composition—markedly distinct from host cytoplasmic machinery—and centrality in vital metabolic pathways make it an attractive target for antimalarial drug development efforts focused on selective inhibition without affecting human host cells.

Mechanism of action

Inhibition of protein synthesis within the apicoplast

Biological functions

Protein synthesisTranslation

Disease associations

Malaria

Safety considerations

Potential for off-target effects on host mitochondrial ribosomesDevelopment of resistance

Interacting drugs

Doxycycline

1 more in the full profile.

Beyond the preview

Go deeper on Apicoplast Ribosome (Plasmodium).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apicoplast Ribosome (Plasmodium).

Explore the full profile